Back to Newsroom
Back to Newsroom

ARIA, EVEP, VIMC and PSDV added to NASDAQ Active Stock Watch List at EPR

Friday, 18 October 2013 10:38 AM

Topic:

New York, NY - (ACCESSWIRE) - 10/18/2013 - Equity Profile Report initiates its NASDAQ Active Stock Watch List adding Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), EV Energy Partners LP (NASDAQ:EVEP), Vimicro International Corp. (NASDAQ:VIMC), and pSivida Corp. (NASDAQ:PSDV) 

Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) an oncology company that focuses on the discovery, development, and commercialization of medicines for cancer patients is currently down (-38.44%) on 26,952,609 shares traded after ARIAD Announced Discontinuation of the Phase 3 Epic Trial of Iclusig in Patients with Newly Diagnosed Chronic Myeloid Leukemia. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) is currently down (-89.46%) from its recent 52-week high, which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll. 

To find out what other Investors are saying about Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) 

Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=ARIA&SubId=AW 

EV Energy Partners LP (NASDAQ:EVEP) a company that engages in the acquisition, development, and production of oil and natural gas properties in the United States is currently down (-4.50%) on 2,216,364 shares traded after EV Energy Partners priced 5 million common unit offering at $36.86 per unit. EV Energy Partners LP (NASDAQ:EVEP) is currently down (-44.86%) from its recent 52-week high, which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll. 

To find out what other Investors are saying about EV Energy Partners LP (NASDAQ:EVEP) 

Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=EVEP&SubId=AW 

Vimicro International Corp. (NASDAQ:VIMC) a company that together with its subsidiaries, engages in the design, development, and marketing of mixed-signal semiconductor products and system-level solutions for the consumer electronics, communications and surveillance markets in Mainland China and Hong Kong is currently up (+7.98%) on 102,072 shares traded. Vimicro International Corp. (NASDAQ:VIMC) is currently up (+116.98%) from its recent 52-week low, which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll. 

To find out what other Investors are saying about Vimicro International Corp. (NASDAQ:VIMC) 

Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=VIMC&SubId=AW 

pSivida Corp. (NASDAQ:PSDV) a company that develops products to deliver drugs and biologics primarily in the United States and the United Kingdom is currently down (-29.21%) on 2,231,065 shares traded after pSivida Reported Complete Response Letter From FDA for ILUVIEN. pSivida Corp. (NASDAQ:PSDV) is currently down (-58.93%) from its recent 52-week high, which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll. 

To find out what other Investors are saying about pSivida Corp. (NASDAQ:PSDV) 

Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=PSDV&SubId=AW 

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed. Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.equityprofilereport.com/

Disclosure: Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
[email protected] 
Topic:
Back to newsroom
Back to Newsroom
Share by: